Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Gila Hyams"'
Autor:
Avi Magid, Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Netanel A. Horowitz, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Yael Shachor-Meyouhas
Publikováno v:
Antibodies, Vol 13, Iss 3, p 63 (2024)
Background: Previous studies showed that the fourth SARS-CoV-2 vaccine dose has a protective effect against infection, as well as against severe disease and death. This study aimed to examine whether knowledge of a high-level antibody after the third
Externí odkaz:
https://doaj.org/article/6feb34e525aa48eaa6caf2908edfa1f8
Autor:
Khetam Hussein, Yael Shachor-Meyouhas, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Jalal Tarabeia, Avi Weissman, Michal Mekel, Gila Hyams, Michael Halberthal
Publikováno v:
Rambam Maimonides Medical Journal, Vol 13, Iss 2, p e0011 (2022)
Background: With the availability of coronavirus disease 2019 (COVID-19) vaccine, concerns have been raised regarding pre-vaccination seroprevalence in healthcare workers (HCW). This study examines the seroprevalence of HCW at an Israeli tertiary med
Externí odkaz:
https://doaj.org/article/142311ef807848438d121b94cb2830d4
Autor:
Yael Shachor-Meyouhas, Halima Dabaja-Younis, Avi Magid, Ronit Leiba, Moran Szwarcwort-Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Nethanel A. Horowitz, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Khetam Hussein
Publikováno v:
Vaccines, Vol 11, Iss 2, p 283 (2023)
Introduction: The fourth SARS-CoV-2 vaccine dose was found to protect against infection and more importantly against severe disease and death. It was also shown that the risk of symptomatic or severe disease was related to the antibody levels after v
Externí odkaz:
https://doaj.org/article/d22a835f0ef34a94b8e2e3f98eb189bb
Autor:
Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Ronit Almog, Ronit Leiba, Avi Weissman, Michal Mekel, Gila Hyams, Nethanel A. Horowitz, Vardit Gepstein, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Yael Shachor-Meyouhas
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1741 (2022)
This study assessed humoral response to the third BNT162b2 dose among healthcare workers (HCW). This prospective cohort study of HCW tested for anti-spike antibodies (LIAISON SARS-CoV-2 S1/S2 IgG assay) at 1, 3, 6, 9, and 12 months after receiving th
Externí odkaz:
https://doaj.org/article/e122aafc9b7b4ade9fe7b2942aa93910
Autor:
Gidon Berger, Yael Shachor-Meyouhas, Michael Halberthal, Yuval Geffen, Avi Weismann, Khetam Hussein, Vardit Gepstein, RN Gila Hyams, Michal Mekel, Netanel A. Horowitz
Publikováno v:
American Journal of Disaster Medicine. 16:35-41
Objective: In response to the coronavirus disease 2019 (COVID-19) pandemic, the Israeli government strategy initially focused on containment. The Ministry of Health mandated isolation of COVID-19 patients in hospitals and instructed healthcare instit
Autor:
Gila Hyams, Michal Mekel, Gidon Berger, Michal Halberthal, Netanel A. Horowitz, Yuval Geffen, Yael Shachor-Meyouhas, Shimon Reisner, Khetam Hussein, Rafael Beyar
Publikováno v:
American Journal of Disaster Medicine. 15:159-167
Objective: This paper describes how a large academic medical center solved the challenges of war preparedness and subsequently adapted them for the COVID-19 pandemic.Setting: A 1,000-bed academic medical center in Northern Israel has faced two extrem
Autor:
Michael Halberthal, Yael Shachor-Meyouhas, Gila Hyams, Michal Mekel, Marielle Kaplan, Moran Szwarcwort-Cohen, Khetam Hussein, Netanel A. Horowitz, Avi Weissman, Halima Dabaja-Younis
Publikováno v:
Vaccine
Introduction The coronavirus disease 2019 (COVID-19) pandemic has led to worldwide vaccination development efforts. In December 2020 the Pfizer BNT162b2 vaccine was approved in the United States. This study describes the first BNT162b2 vaccine dose e
Autor:
Michal Mekel, Moran Szwarcwort-Cohen, Ronit Almog, Michael Halberthal, Jalal Tarabeia, Halima Dabaja-Younis, Nethanel A. Horowitz, Khetam Hussein, Vardit Gepstein, Neta Petersiel, Avi Weissman, Hagar Cohen Saban, Yael Shachor-Meyouhas, Itamar Netzer, Gila Hyams
Publikováno v:
Clinical Microbiology and Infection. 28:450.e1-450.e4
Objectives We evaluated antibody response to the BNT162B2 vaccine among healthcare workers (HCWs) to identify factors associated with decreased immunogenicity. Methods This prospective cohort study included consenting HCWs who completed a questionnai
Autor:
David Yarnitsky, Shiri Fadel, Julia Begal, Elliot Sprecher, Noam Bosak, Hen Ben Lulu, Liat Honigman, Osnat Aspis, Rabia Salame, David Hochstein, Yelena Granovsky, Michele Sterling, Maya Reshef, Gila Hyams, Hany Bahouth, Shahar Grunner, Pora Kuperman, Michal Granot
Publikováno v:
Neurology. 91:e931-e938
ObjectiveTo characterize the pain-related somatosensory and psychological presentation of very early acute patients with a mild traumatic brain injury (mTBI).MethodsPatients with an mTBI participated in a prospective observational study undergoing cl
Publikováno v:
Clinical nutrition ESPEN. 22
Summary Background & aims Nurses have crucial roles in optimizing nutritional therapy for patients. The aim of this study was to explore nurses' perceptions regarding barriers to effective nutritional therapy. Methods Hospital-based nurses completed